Healthcare -
Biotechnology - NASDAQ - US
$ 5.66
7.2 %
$ 387 M
Market Cap
-2.48
P/E
OLMA - COST OF REVENUE
Cost of Revenue OLMA - Olema Pharmaceuticals, Inc.
377 K
LAST VALUE
-52.39%
2 YEAR CAGR
114.80%
5 YEAR CAGR
0.00%
10 YEAR CAGR